# EDGAR Filing Document

**Accession Number:** 0000924383
**File Stem:** 0000950170-25-108916
**Filing Date:** 2025-8
**Character Count:** 20677
**Document Hash:** 9d15492db89d517bbad56fc624ff3d9a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-108916.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0000950170-25-108916

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250814

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genasys Inc.
- **CENTRAL INDEX KEY:** 0000924383
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD AUDIO & VIDEO EQUIPMENT [3651]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 870361799
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-24248
- **FILM NUMBER:** 251219616

**BUSINESS ADDRESS:**
- **STREET 1:** 16262 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127
- **BUSINESS PHONE:** 858-676-1112

**MAIL ADDRESS:**
- **STREET 1:** 16262 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LRAD Corp
- **DATE OF NAME CHANGE:** 20100326

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERICAN TECHNOLOGY CORP /DE/
- **DATE OF NAME CHANGE:** 19940602

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## **FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** August 14, 2025<br>

------

Genasys Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 000-24248 | 87-0361799 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 16262 West Bernardo Drive |  |  |
| San Diego**,** California |  | 92127 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 858 676-1112<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common stock, $0.00001 par value per share | GNSS | The Nasdaq Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## **Item 2.02 Results of Operations and Financial Condition.** 
The following information is furnished pursuant to Item 2.02, "Results of Operations and Financial Condition," and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the "Company"), whether made before or after the date hereof, regardless of any general incorporation language in such filing.

On August 14, 2025, the Company issued a press release regarding its financial results for the fiscal quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto, and is incorporated by reference herein.

## **Item 9.01 Financial Statements and Exhibits.** 
(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | [<u>Financial Results Press Release, dated August 14, 2025, issued by the Company.</u>](gnss-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | Genasys Inc. |
| Date: | August 14, 2025 | By:  | /s/ Cassandra L. Hernandez-Monteon |
|  |  |  | Cassandra L. Hernandez-Monteon<br>Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![img147471742_0.jpg](img147471742_0.jpg)

**Genasys Inc. Reports Fiscal Third Quarter 2025 Financial Results**

***Instrumentation and Software for 1***<sup>st</sup> ***Dam Accepted in Puerto Rico***

**SAN DIEGO – August 14, 2025 Genasys Inc. (NASDAQ: GNSS),** the leader in Protective Communications, today announced financial results for the Company's fiscal third quarter ended June 30, 2025.

Richard S. Danforth, Chief Executive Officer of Genasys, Inc., commented, "As expected, business in the second half of fiscal 2025 has accelerated dramatically. Just this morning, we finally received confirmation that the remaining deposit on the third group of dams is being transferred today. Across Puerto Rico, installation on all nine dams in the first two groups is underway. Additionally, at the end of July 2025, the US Army issued an RFQ for the initial production order in support of the CROWS (Common Remote Operated Weapons Station) program of record. Our understanding is that procurement is nearly complete, and a purchase order is being prepared."

**Fiscal 3Q 2025 Financial Summary**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Revenue of $9.9 million, versus $7.2 million in 3Q 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•GAAP operating loss of ($5.9) million, versus ($5.4) million in 3Q 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•GAAP net loss of ($6.5) million, versus ($6.7) million in 3Q 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•GAAP net loss per share ($0.14), versus ($0.15) in 3Q 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA of ($4.8) million, versus ($4.3) million in 3Q 2024.

------

**Business Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;•Received acceptance from Puerto Rico Electric Power Authority (PREPA) for the installation of instrumentation on the first dam and the activation of the software system to be utilized across the Early Warning System (EWS).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Executed cost reduction actions expected to reduce operating expenses by $2.5 million annually, beginning 1Q 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Named Cassandra Monteon interim Chief Financial Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Generated $4.3 million in revenues from Puerto Rico EWS project in fiscal 3Q 2025

**Business Outlook**

Genasys is well underway with the implementation of the Puerto Rico EWS project. In the third fiscal quarter, the Company recorded $4.3 million in project-related revenue, with very little profit margin. As installations are completed, revenue and profit growth will accelerate consistent with the percentage-of-completion accounting methodology. To date, Genasys has recognized $5.6 million of revenue with less than 30% gross margins. As the project progresses and profits on prior instrumentation revenues can be realized, project margins will improve significantly, as those revenues will be recognized at 100% gross margin. It is important to note that revenue and profit recognition continues to be significantly different from the expected cash-based accounting of the project. As each dam's system is completed and accepted, Genasys is to be paid the remaining 40% of total value of each dam. Based on the current production and delivery schedules, and installation timelines, Genasys continues to expect to realize between $15 million and $20 million in Puerto Rico related revenue in fiscal 2025, with revenue and profit recognition on the project accelerating significantly in fiscal 2026.

Excluding the efforts in Puerto Rico, hardware bookings continue to improve year over year. The US Army is finalizing the procurement process for the initial production order for the CROWS AHD program, Genasys expects that this initial order will be for $8.0 million to $8.5 million of LRAD equipment. That order will take fiscal 2025 hardware bookings to date 10% higher than bookings for all fiscal 2024, excluding the Puerto Rico project. With CROWS AHD, Genasys' hardware backlog, excluding the Puerto Rico project, will be over $16 million.

Software bookings continued to be soft in the fiscal third quarter. While numerous federal funding sources have officially been restarted, the increased scrutiny and ongoing uncertainty has impacted customers throughout the nation all the way up from local to state, and even federal agencies. Our Software pipeline continues to expand across all our product offerings, and we continue to expect deal conversions to improve and accelerate as access to federal funds normalizes. In the interim, however, Genasys has taken actions to reduce operating expenses associated with our software business. Beginning in the first fiscal quarter of 2026, we believe those combined actions will deliver approximately $2.5 million in annualized savings.

Operating expenses in the third fiscal quarter were down 3.9% sequentially and 6.8% year over year, owing to operational and cost discipline and the absence of certain legal and professional fees. Fiscal

------

fourth quarter 2025 operating expenses, inclusive of severance costs, are expected to be similar to fiscal third quarter 2025 levels, with the savings discussed above beginning to be realized in the fiscal first quarter of 2026.

While the $5.5 million in cash, cash equivalents and marketable securities we are reporting at the end of June is lower than we would prefer, upcoming payments for invoices already issued from Puerto Rico and cash flows from the US Army order give us the confidence that we have adequate capital to operate and capture the profits embedded in our existing backlog.

**Fiscal 3Q 2025 Financial Review**

Fiscal third quarter revenue was $9.9 million, a 38% increase from $7.2 million in the prior year's fiscal third quarter. Software revenue increased 7% while hardware revenue increased 50%, compared with the fiscal 2024 third quarter. Within software, quarterly recurring revenue increased 8% year over year and ARR finished the quarter at $8.7 million.

Gross profit margin was 26.3%, compared with 52.8% in the third quarter of fiscal 2024. The depressed gross margin is primarily attributable to the percentage-of-completion accounting associated with the Puerto Rico project and the underutilization of hardware revenue.

Operating expenses of $8.5 million decreased from $9.1 million in the fiscal third quarter of 2024. Selling, general and administrative expenses were essentially flat year over year at $6.4 million in the quarter ended June 30, 2025. Research and development expenses decreased 16% year over year to $2.1 million.

GAAP net loss in the quarter was ($6.5) million, or ($0.14) per share, compared with a GAAP net loss of ($6.7) million, or ($0.15) per share, in the third quarter of fiscal 2024.

Excluding other income and expense, net income tax expense (benefit), depreciation, stock-based compensation and amortization of intangibles, adjusted EBITDA was ($4.8) million for the third quarter of fiscal 2025, compared with ($4.3) million for the prior fiscal year period.

Cash, cash equivalents and marketable securities totaled $5.5 million as of June 30, 2025, compared with $13.1 million as of September 30, 2024.

We include in this press release the non-GAAP operational metrics of adjusted EBITDA, which we believe provide helpful information to investors with respect to evaluating the Company's performance. Adjusted EBITDA represents our net loss before other income and expense, net, income tax expense (benefit), depreciation and amortization expense and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends and to

------

generate future operating plans, make strategic decisions regarding allocation of capital and invest in initiatives that are focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis.

**Webcast and Conference Call Details** 

Management will host a conference call to discuss the financial results for the third quarter of fiscal year 2025 this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (862) 298-0702. A webcast will also be available at the following link: https://app.webinar.net/5vKnwNmje6L

Questions to management may be submitted before the call by emailing them to: <u>ir@genasys.com</u>. A replay of the webcast will be available approximately four hours after the presentation on the investors page of the Company's website.

**About Genasys Inc.**

Genasys Inc. (NASDAQ: GNSS) is the global leader in Protective Communications. Incorporating the most comprehensive portfolio of preparedness, response, and analytics software and hardware systems, including the Company's Long Range Acoustic Device® (LRAD®), the Genasys Protect platform is designed around one premise: ensuring organizations and public safety agencies are Ready when it matters™. Protecting people and saving lives for over 40 years, Genasys covers more than 155 million people in all 50 states and in over 100 countries worldwide. For more information, visit genasys.com.

**Forward-Looking Statements**

Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and uncertainties in these forward-looking statements include without limitation the business impact of geopolitical conflicts, and other causes that may affect our supply chain, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the "Risk Factors" section of the Company's Form 10-K for the fiscal year ended September 30, 2024. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise

------

specifically stated.

**Investor Relations Contacts**

Brian Alger, CFA

SVP, IR and Corporate Development

<u>ir@genasys.com</u>

(858) 676-0582

------

**Genasys Inc.**

**Consolidated Balance Sheets**

**(Unaudited - in thousands)**

---

| | | |
|:---|:---|:---|
|  | **June 30,<br>2025** | **September 30,<br>2024** |
|  | **(Unaudited)** |  |
| **ASSETS** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $5339 | $4945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term marketable securities | 120 | 7945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 95 | 95 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 4648 | 3283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 2846 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 11426 | 7313 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 7458 | 2559 |
| **Total current assets** | 31932 | 26140 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term marketable securities |  | 249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term restricted cash | 585 | 250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 1169 | 1291 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 13451 | 13329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 6724 | 8506 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right of use assets, net | 2550 | 3110 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 982 | 1061 |
| **Total assets** | $57393 | $53936 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $7797 | $4034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 23473 | 9030 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, current portion | 1075 | 1021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable, at fair value | 17050 |  |
| **Total current liabilities** | 49395 | 14085 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable, at fair value |  | 12010 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warrant liability | 2080 | 6640 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred revenue | 294 | 369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, noncurrent | 2465 | 3269 |
| **Total liabilities** | 54234 | 36373 |
| **Total stockholders' equity** | 3159 | 17563 |
| **Total liabilities and stockholders' equity** | $57393 | $53936 |

---

------

**Genasys Inc.**

**Consolidated Statements of Operations**

**(Unaudited - in thousands, except per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Nine Months Ended<br>June 30,** | **Nine Months Ended<br>June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| **Revenues** | $9857 | $7167 | $23729 | $17267 |
| **Cost of revenues** | 7260 | 3383 | 15344 | 9827 |
| **Gross profit** | 2597 | 3784 | 8385 | 7440 |
|  | 26.3% | 52.8% | 35.3% | 43.1% |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 6422 | 6649 | 19904 | 19806 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 2100 | 2496 | 6602 | 7218 |
| Total operating expenses | 8522 | 9145 | 26506 | 27024 |
| Loss from operations | (5925) | (5361) | (18121) | (19584) |
| Other income, net | (554) | (1363) | 1496 | (1236) |
| Loss before income taxes | (6479) | (6724) | (16625) | (20820) |
| Income tax (expense) benefit | 8 | (42) | 79 | (476) |
| **Net loss** | $(6487) | $(6682) | $(16704) | $(20344) |
| **Net loss per common share - basic and diluted** | $(0.14) | $(0.15) | $(0.37) | $(0.46) |
| **Weighted average common shares outstanding - basic and diluted** | 45155 | 44598 | 45023 | 44217 |
| **Reconciliation of GAAP measures to non-GAAP measures** |  |  |  |  |
| Net loss | $(6487) | $(6682) | $(16704) | $(20344) |
| Other income, net | 554 | 1363 | (1496) | 1236 |
| Income tax expense (benefit) | 8 | (42) | 79 | (476) |
| Depreciation and amortization | 685 | 733 | 2114 | 2193 |
| Stock based compensation | 459 | 299 | 1264 | 1269 |
| **Adjusted EBITDA** | $(4781) | $(4329) | $(14743) | $(16122) |

---

------